0

Journal Articles

in Alzheimer Disease
 21-24 of 24 Articles
Original Investigation |  July 08, 2002 FREE
The Debate Over Research on Stored Biological Samples:  What Do Sources Think?
Dave Wendler, PhD; Ezekiel Emanuel, MD, PhD
Arch Intern Med. 2002;162(13):1457-1462. doi:10.1001/archinte.162.13.1457.
Review Article |  April 26, 1999 FREE
Diagnosis, Management, and Treatment of Alzheimer Disease:  A Guide for the Internist
Stephanie S. Richards, MD; Hugh C. Hendrie, MB, ChB
Arch Intern Med. 1999;159(8):789-798. doi:10.1001/archinte.159.8.789.
Editorial |  May 11, 1998
New Drug Treatments for Alzheimer Disease
Eric B. Larson, MD, MPH
Arch Intern Med. 1998;158(9):941-942. doi:10.1001/archinte.158.9.941.
Original Investigation |  May 11, 1998 FREE
Donepezil Improves Cognition and Global Function in Alzheimer Disease:  A 15-Week, Double-blind, Placebo-Controlled Study
Sharon L. Rogers, PhD; Rachelle S. Doody, MD, PhD; Richard C. Mohs, PhD; et al.
Arch Intern Med. 1998;158(9):1021-1031. doi:10.1001/archinte.158.9.1021.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Neurology
Original Contribution  |  June 17, 2013
Dissociable Effects of Alzheimer Disease and White Matter Hyperintensities on Brain Metabolism
Thaddeus J. Haight, PhD; Susan M. Landau, PhD; Owen Carmichael, PhD; et al.
JAMA Neurology
Original Contribution  |  April 15, 2013
C9orf72 Hexanucleotide Repeat Expansions in Clinical Alzheimer Disease
Matthew Harms, MD; Bruno A. Benitez, MD; Nigel Cairns, PhD; et al.
JAMA Neurology
Observation  |  April 22, 2013
Progranulin Mutations as Risk Factors for Alzheimer Disease
David C. Perry, MD; Manja Lehmann, PhD; Jennifer S. Yokoyama, PhD; et al.
JAMA Neurology
Viewpoint  |  April 29, 2013
DNA Aβ42 Vaccination as Possible Alternative Immunotherapy for Alzheimer Disease
Roger N. Rosenberg, MD; Doris Lambracht-Washington, PhD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems